Previous research by Maksimenko et al. demonstrated that triple-negative breast cancer (TNBC) patients carrying pathogenic BRCA1 allelic variants show significantly higher breast cancer-specific survival [7]. The gene discussed is BRCA1; the disease is breast carcinoma.